Merck's NEWest Drug: Idvynso, also a Once Weekly Drug & Once Monthly PrEP!
Raif Derrazi
The video features an interview with Louisa Stam, a physician scientist at Merck, discussing the recent FDA approval of Adenzo for treating HIV in individuals who are already virally suppressed. Adenzo is a once-daily oral tablet that combines dolutegravir and elvitegravir, representing a significan …